We also found that fibroblast growth factor 3 (FGF3) (Fig. 4F), upstream of KRAS, is associated with a hypomethylated DMR in its promoter region in obesity and is even further hypomethylated in CRC. The gene discussed is KRAS; the disease is colorectal carcinoma.